HEADER HYDROLASE/HYDROLASE INHIBITOR 16-DEC-91 1APW TITLE CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO TITLE 2 PENICILLOPEPSIN: DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING TITLE 3 PEPTIDES CAVEAT 1APW HSY E 399 HAS WRONG CHIRALITY AT ATOM C2 HSY E 399 HAS WRONG CAVEAT 2 1APW CHIRALITY AT ATOM C3 HSY E 399 HAS WRONG CHIRALITY AT ATOM CAVEAT 3 1APW C4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PENICILLOPEPSIN; COMPND 3 CHAIN: E; COMPND 4 EC: 3.4.23.20; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: INHIBITOR ISOVALERYL (IVA)-VAL-VAL-DIFLUOROSTATINE-N- COMPND 8 METHYLAMINE; COMPND 9 CHAIN: I; COMPND 10 ENGINEERED: YES; COMPND 11 OTHER_DETAILS: TRANSITION STATE MIMIC SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PENICILLIUM JANTHINELLUM; SOURCE 3 ORGANISM_COMMON: PENICILLIUM VITALE; SOURCE 4 ORGANISM_TAXID: 5079; SOURCE 5 MOL_ID: 2 KEYWDS ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.R.SIELECKI,M.N.G.JAMES REVDAT 6 29-JUL-20 1APW 1 CAVEAT COMPND REMARK HETNAM REVDAT 6 2 1 LINK SITE ATOM REVDAT 5 13-JUL-11 1APW 1 VERSN REVDAT 4 25-AUG-09 1APW 1 SOURCE REVDAT 3 24-FEB-09 1APW 1 VERSN REVDAT 2 01-APR-03 1APW 1 JRNL REVDAT 1 31-JAN-94 1APW 0 JRNL AUTH M.N.JAMES,A.R.SIELECKI,K.HAYAKAWA,M.H.GELB JRNL TITL CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND JRNL TITL 2 TO PENICILLOPEPSIN: DIFLUOROSTATINE- AND JRNL TITL 3 DIFLUOROSTATONE-CONTAINING PEPTIDES. JRNL REF BIOCHEMISTRY V. 31 3872 1992 JRNL REFN ISSN 0006-2960 JRNL PMID 1567842 JRNL DOI 10.1021/BI00130A019 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.N.G.JAMES,A.R.SIELECKI REMARK 1 TITL ASPARTIC PROTEINASES AND THEIR CATALYTIC PATHWAY REMARK 1 EDIT F.A.JURNAK, A.MCPHERSON REMARK 1 REF BIOLOGICAL MACROMOLECULES V. 3 414 1987 REMARK 1 REF 2 AND ASSEMBLIES REMARK 1 PUBL JOHN WILEY AND SONS,NEW YORK REMARK 1 REFN ISSN 0-471-85142-6 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.N.G.JAMES,A.R.SIELECKI REMARK 1 TITL STEREOCHEMICAL ANALYSIS OF PEPTIDE BOND HYDROLYSIS CATALYZED REMARK 1 TITL 2 BY THE ASPARTIC PROTEINASE PENICILLOPEPSIN REMARK 1 REF BIOCHEMISTRY V. 24 3701 1985 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.N.G.JAMES,A.R.SIELECKI,T.HOFMANN REMARK 1 TITL X-RAY DIFFRACTION STUDIES ON PENICILLOPEPSIN AND ITS REMARK 1 TITL 2 COMPLEXES: THE HYDROLYTIC MECHANISM REMARK 1 EDIT V.KOSTKA REMARK 1 REF ASPARTIC PROTEINASES AND 163 1985 REMARK 1 REF 2 THEIR INHIBITORS REMARK 1 PUBL WALTER DE GRUYTER & CO.,BERLIN AND NEW YORK REMARK 1 REFN REMARK 1 REFERENCE 4 REMARK 1 AUTH T.HOFMANN,R.S.HODGES,M.N.G.JAMES REMARK 1 TITL EFFECT OF PH ON THE ACTIVITIES OF PENICILLOPEPSIN AND REMARK 1 TITL 2 RHIZOPUS PEPSIN AND A PROPOSAL FOR THE PRODUCTIVE SUBSTRATE REMARK 1 TITL 3 BINDING MODE IN PENICILLOPEPSIN REMARK 1 REF BIOCHEMISTRY V. 23 635 1984 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 5 REMARK 1 AUTH M.N.G.JAMES,A.R.SIELECKI,J.MOULT REMARK 1 TITL CRYSTALLOGRAPHIC ANALYSIS OF A PEPSTATIN ANALOGUE BINDING TO REMARK 1 TITL 2 THE ASPARTYL PROTEINASE PENICILLOPEPSIN AT 1.8 ANGSTROMS REMARK 1 TITL 3 RESOLUTION REMARK 1 EDIT V.J.HRUBY, D.H.RICH REMARK 1 REF PEPTIDES: STRUCTURE AND 521 1983 REMARK 1 REF 2 FUNCTION, PROCEEDINGS OF THE REMARK 1 REF 3 OF THE EIGHTH AMERICAN REMARK 1 REF 4 PEPTIDE SYMPOSIUM REMARK 1 PUBL PIERCE CHEMICAL COMPANY,ROCKFORD,IL REMARK 1 REFN REMARK 1 REFERENCE 6 REMARK 1 AUTH M.N.G.JAMES,A.R.SIELECKI REMARK 1 TITL STRUCTURE AND REFINEMENT OF PENICILLOPEPSIN AT 1.8 ANGSTROMS REMARK 1 TITL 2 RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 163 299 1983 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 7 REMARK 1 AUTH M.N.G.JAMES,A.SIELECKI,F.SALITURO,D.H.RICH,T.HOFMANN REMARK 1 TITL CONFORMATIONAL FLEXIBILITY IN THE ACTIVE SITES OF ASPARTYL REMARK 1 TITL 2 PROTEINASES REVEALED BY A PEPSTATIN FRAGMENT BINDING TO REMARK 1 TITL 3 PENICILLOPEPSIN REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 79 6137 1982 REMARK 1 REFN ISSN 0027-8424 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PROLSQ REMARK 3 AUTHORS : KONNERT,HENDRICKSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 22464 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.131 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2401 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 295 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.016 ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1APW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000171111. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 48.82000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.29000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 48.82000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 23.29000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1770 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH E 563 LIES ON A SPECIAL POSITION. REMARK 375 HOH E 584 LIES ON A SPECIAL POSITION. REMARK 375 HOH E 585 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR E 175 O4 SO4 E 365 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SER E 52 O - C - N ANGL. DEV. = 13.3 DEGREES REMARK 500 ASP E 119 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 PHE E 141 CB - CG - CD1 ANGL. DEV. = -5.0 DEGREES REMARK 500 VAL E 155 CG1 - CB - CG2 ANGL. DEV. = -9.7 DEGREES REMARK 500 ASP E 206 CB - CG - OD1 ANGL. DEV. = 6.2 DEGREES REMARK 500 ASP E 222 CB - CG - OD1 ANGL. DEV. = 7.1 DEGREES REMARK 500 ASP E 222 CB - CG - OD2 ANGL. DEV. = -6.2 DEGREES REMARK 500 DFI I 1 CA - C - N ANGL. DEV. = 17.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE E 208 -177.89 -171.10 REMARK 500 ASP E 279 86.10 -155.33 REMARK 500 DFI I 1 -146.42 -69.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 DFI I 1 29.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 HSY E 399 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1APT RELATED DB: PDB REMARK 900 RELATED ID: 1APU RELATED DB: PDB REMARK 900 RELATED ID: 1APV RELATED DB: PDB DBREF 1APW E 1 323 UNP P00798 PENP_PENJA 1 323 DBREF 1APW I 4 1A PDB 1APW 1APW 4 1 SEQRES 1 E 323 ALA ALA SER GLY VAL ALA THR ASN THR PRO THR ALA ASN SEQRES 2 E 323 ASP GLU GLU TYR ILE THR PRO VAL THR ILE GLY GLY THR SEQRES 3 E 323 THR LEU ASN LEU ASN PHE ASP THR GLY SER ALA ASP LEU SEQRES 4 E 323 TRP VAL PHE SER THR GLU LEU PRO ALA SER GLN GLN SER SEQRES 5 E 323 GLY HIS SER VAL TYR ASN PRO SER ALA THR GLY LYS GLU SEQRES 6 E 323 LEU SER GLY TYR THR TRP SER ILE SER TYR GLY ASP GLY SEQRES 7 E 323 SER SER ALA SER GLY ASN VAL PHE THR ASP SER VAL THR SEQRES 8 E 323 VAL GLY GLY VAL THR ALA HIS GLY GLN ALA VAL GLN ALA SEQRES 9 E 323 ALA GLN GLN ILE SER ALA GLN PHE GLN GLN ASP THR ASN SEQRES 10 E 323 ASN ASP GLY LEU LEU GLY LEU ALA PHE SER SER ILE ASN SEQRES 11 E 323 THR VAL GLN PRO GLN SER GLN THR THR PHE PHE ASP THR SEQRES 12 E 323 VAL LYS SER SER LEU ALA GLN PRO LEU PHE ALA VAL ALA SEQRES 13 E 323 LEU LYS HIS GLN GLN PRO GLY VAL TYR ASP PHE GLY PHE SEQRES 14 E 323 ILE ASP SER SER LYS TYR THR GLY SER LEU THR TYR THR SEQRES 15 E 323 GLY VAL ASP ASN SER GLN GLY PHE TRP SER PHE ASN VAL SEQRES 16 E 323 ASP SER TYR THR ALA GLY SER GLN SER GLY ASP GLY PHE SEQRES 17 E 323 SER GLY ILE ALA ASP THR GLY THR THR LEU LEU LEU LEU SEQRES 18 E 323 ASP ASP SER VAL VAL SER GLN TYR TYR SER GLN VAL SER SEQRES 19 E 323 GLY ALA GLN GLN ASP SER ASN ALA GLY GLY TYR VAL PHE SEQRES 20 E 323 ASP CYS SER THR ASN LEU PRO ASP PHE SER VAL SER ILE SEQRES 21 E 323 SER GLY TYR THR ALA THR VAL PRO GLY SER LEU ILE ASN SEQRES 22 E 323 TYR GLY PRO SER GLY ASP GLY SER THR CYS LEU GLY GLY SEQRES 23 E 323 ILE GLN SER ASN SER GLY ILE GLY PHE SER ILE PHE GLY SEQRES 24 E 323 ASP ILE PHE LEU LYS SER GLN TYR VAL VAL PHE ASP SER SEQRES 25 E 323 ASP GLY PRO GLN LEU GLY PHE ALA PRO GLN ALA SEQRES 1 I 5 IVA VAL VAL DFI NME MODRES 1APW SER E 3 SER GLYCOSYLATION SITE MODRES 1APW THR E 7 THR GLYCOSYLATION SITE HET IVA I 4 6 HET DFI I 1 13 HET NME I 1A 2 HET MAN E 328 11 HET HSY E 399 9 HET SO4 E 365 5 HET DMF I 587 5 HETNAM IVA ISOVALERIC ACID HETNAM DFI 2,2-DIFLUOROSTATINE HETNAM NME METHYLAMINE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM HSY ALPHA-L-XYLOPYRANOSE HETNAM SO4 SULFATE ION HETNAM DMF DIMETHYLFORMAMIDE FORMUL 2 IVA C5 H10 O2 FORMUL 2 DFI C8 H15 F2 N O3 FORMUL 2 NME C H5 N FORMUL 3 MAN C6 H12 O6 FORMUL 4 HSY C5 H10 O5 FORMUL 5 SO4 O4 S 2- FORMUL 6 DMF C3 H7 N O FORMUL 7 HOH *295(H2 O) HELIX 1 1 ALA E 12 GLU E 15 5 4 HELIX 2 2 PRO E 47 GLN E 51 5 5 HELIX 3 3 ASN E 58 GLY E 63 1 6 HELIX 4 4 SER E 109 ASP E 115 1 7 HELIX 5 5 PHE E 126 ASN E 130 5 5 HELIX 6 6 THR E 139 LYS E 145 1 7 HELIX 7 7 ASP E 171 LYS E 174 5 4 HELIX 8 8 ASP E 222 SER E 231 1 10 HELIX 9 9 PRO E 268 LEU E 271 5 4 HELIX 10 10 GLY E 299 LYS E 304 1 6 SHEET 1 A 7 TYR E 263 VAL E 267 0 SHEET 2 A 7 PHE E 256 ILE E 260 -1 O PHE E 256 N VAL E 267 SHEET 3 A 7 SER E 192 ALA E 200 -1 N ASP E 196 O SER E 259 SHEET 4 A 7 GLN E 203 ALA E 212 -1 O GLN E 203 N ALA E 200 SHEET 5 A 7 SER E 296 PHE E 298 1 N SER E 296 O SER E 209 SHEET 6 A 7 LEU E 219 LEU E 221 -1 O LEU E 220 N ILE E 297 SHEET 7 A 7 ILE E 287 SER E 289 1 N GLN E 288 O LEU E 219 SHEET 1 B 4 GLN E 237 ASP E 239 0 SHEET 2 B 4 GLY E 244 ASP E 248 -1 O GLY E 244 N ASP E 239 SHEET 3 B 4 THR E 282 GLY E 285 -1 N CYS E 283 O PHE E 247 SHEET 4 B 4 ASN E 273 PRO E 276 -1 N TYR E 274 O LEU E 284 SSBOND 1 CYS E 249 CYS E 283 1555 1555 2.07 LINK OG SER E 3 C1 MAN E 328 1555 1555 1.43 LINK OG1 THR E 7 C5 HSY E 399 1555 1555 1.41 LINK N NME I 1A C DFI I 1 1555 1555 1.32 LINK N DFI I 1 C VAL I 2 1555 1555 1.34 LINK N VAL I 3 C IVA I 4 1555 1555 1.31 CISPEP 1 GLN E 133 PRO E 134 0 1.43 CISPEP 2 GLY E 314 PRO E 315 0 -2.26 CRYST1 97.640 46.580 66.440 90.00 116.12 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010242 0.000000 0.005022 0.00000 SCALE2 0.000000 0.021468 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016763 0.00000